ESR1 and breast carcinoma: Unlike estrogen receptor positive (ER+) breast cancer, which can be effectively treated with aromatase inhibitors, tamoxifen or other selective estrogen receptor modulators (SERMs), there is no targeted therapy currently approved for TNBC.